Riskpilot← Back to searchSign inGet full accessGENO GLOBAL AS
ASActiveOrg 985194378Storhamargata 44, 2317 HamarSupport activities for animal production · NACE 0162Est. 20025 employeeswww.geno.no
Revenue 2024
NOK 23,3M
-16% vs 2023
EBITDA margin
-23.7%
-62% vs 2023
Equity ratio
-21.9%
Financial strength
Net profit 2024
NOK -12,8M
-127% vs 2023
| Revenue | NOK 23,3M | -16% |
| EBITDA | NOK -5,5M | -62% |
| Net profit | NOK -12,8M | -127% |
| Total assets | NOK 11,4M | -60% |
| Equity | NOK -2,5M | -120% |
| Employees | 5 | — |
Legal name
GENO GLOBAL AS
Org number
985194378
Legal form
Aksjeselskap
NACE code
0162 · Support activities for animal production
Founded
13. desember 2002
Share capital
NOK 19 724 000
Employees
5 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder og styrets leder i fellesskap.
Company purpose
Salg på det internasjonale markedet av avlsmateriale, herunder sæd, embryo og livdyr og andre produkter som faller naturlig sammen med dette. Selskapet kan i tillegg, ved kjøp og salg av aksjer eller på annen måte delta i, eller gjøre seg interessert i andre selskaper som driver lignende virksomhet.
Address
Storhamargata 44, 2317 Hamar
Website
www.geno.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 5 012 | 8 136 | 9 666 | 10 028 | 16 857 | 11 171 | 14 030 | 14 054 | 18 512 | 25 610 | 25 009 | 27 680 | 22 447 | 39 929 | 27 735 | 23 350 |
| Staff expenses | −1 537 | −1 689 | −1 679 | −1 783 | −1 958 | −2 045 | −3 294 | −1 361 | −1 019 | −1 664 | −1 892 | −1 585 | −1 311 | −1 | −5 172 | −6 907 |
| EBITDA | −3 251 | −1 971 | −660 | −1 986 | 1 311 | −1 150 | 2 336 | 871 | 4 489 | 2 591 | 481 | 2 084 | 1 641 | −1 759 | −3 414 | −5 530 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −435 | −653 | −1 798 |
| EBIT | −3 251 | −1 971 | −660 | −1 986 | 1 311 | −1 150 | 2 336 | 871 | 4 489 | 2 591 | 481 | 2 084 | 1 641 | −2 195 | −4 067 | −7 328 |
| Net financials | −132 | −174 | −81 | −299 | 1 180 | 1 231 | 1 715 | −8 213 | 654 | −6 767 | −373 | −25 | 324 | −5 800 | −1 581 | −4 471 |
| Profit before tax | −3 383 | −2 145 | −740 | −2 285 | 2 491 | 81 | 4 051 | −7 342 | 5 142 | −4 176 | 108 | 2 058 | 1 965 | −7 995 | −5 648 | −11 799 |
| Tax | −940 | −593 | −195 | −606 | 668 | −334 | 1 011 | −141 | 1 033 | 650 | 26 | 457 | 332 | −577 | −0 | 1 018 |
| Net profit | −2 443 | −1 552 | −545 | −1 679 | 1 823 | 414 | 3 040 | −7 201 | 4 110 | −4 826 | 82 | 1 602 | 1 633 | −7 417 | −5 648 | −12 818 |
| Item | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 12 465 | 12 001 | 12 098 | 15 513 | 25 403 | 24 646 | 34 703 | 27 637 | 24 859 | 23 550 | 19 361 | 21 241 | 24 033 | 31 730 | 28 500 | 11 403 |
| Equity | 6 573 | 5 021 | 4 476 | 7 797 | 9 620 | 9 467 | 12 507 | 5 306 | 9 416 | 4 590 | 4 672 | 6 274 | 7 907 | 490 | 12 348 | −2 501 |
| Long-term debt | −9 | −30 | −120 | −80 | 13 029 | 13 029 | 19 230 | 16 230 | 11 230 | 7 230 | 7 230 | 7 230 | 7 230 | 7 230 | 9 724 | 9 724 |
| Short-term debt | 882 | 1 950 | 2 502 | 2 635 | 2 660 | 1 666 | 2 421 | 6 100 | 4 213 | 11 730 | 7 459 | 7 737 | 8 895 | 24 009 | 6 427 | 4 180 |
| Total debt | 5 882 | 6 950 | 7 502 | 7 635 | 15 690 | 14 695 | 21 651 | 22 330 | 15 443 | 18 960 | 14 689 | 14 968 | 16 125 | 31 240 | 16 152 | 13 904 |
EBITDA margin
-23.7%
This company
15.8%
Market median
-250% vs market
20092024
Equity ratio
-21.9%
This company
38.2%
Market median
-157% vs market
20092024
Return on equity
-1281773400.0%
This company
18.4%
Market median
-6966159883% vs market
20092024
Net profit margin
-54.9%
This company
8.1%
Market median
-778% vs market
20092024
Asset turnover
2.05×
This company
1.12×
Market median
+83% vs market
20092024
Debt / equity
5.56×
This company
0.62×
Market median
-797% vs market
20092024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-01-01 – 2012-12-31
- Annual report 2011Filed via Brønnøysundsregistrene · Period 2011-01-01 – 2011-12-31
- Annual report 2010Filed via Brønnøysundsregistrene · Period 2010-01-01 – 2010-12-31
- Annual report 2009Filed via Brønnøysundsregistrene · Period 2009-01-01 – 2009-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
TA Chief Executive Officer | Chief Executive Officer | 2024 | — | — |
KM Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2020 | — | — | |
| Chairman | 2023 | — | — | |
| Board of Directors | 2023 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Geno Sa | Company | 100.0% | 100.0% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Geno Sa
GENO GLOBAL AS Board members of GENO GLOBAL AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Thor Arne Sletmoen | Chief Executive Officer | 0 companies |
| Katherine Moana Stai | Chief Executive Officer | 0 companies |
| Lars Skramstad | Board of Directors | 0 companies |
| Mari Bjørke | Board of Directors | 0 companies |
| Kristin Malonæs | Chairman | 0 companies |
| Pål Bråthen | Board of Directors | 0 companies |